Is the anti-psychotic, 10-(3-(dimethylamino)propyl)phenothiazine (promazine), a potential drug with which to treat SARS infections?: Lack of efficacy of promazine on SARS-CoV replication in a mouse model
- 31 August 2008
- journal article
- Published by Elsevier in Antiviral Research
- Vol. 79 (2) , 105-113
- https://doi.org/10.1016/j.antiviral.2007.12.005
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Enhancement of the infectivity of SARS-CoV in BALB/c mice by IMP dehydrogenase inhibitors, including ribavirinAntiviral Research, 2006
- Modeling the Early Events of Severe Acute Respiratory Syndrome Coronavirus Infection In VitroJournal of Virology, 2006
- Coronavirus Pathogenesis and the Emerging Pathogen Severe Acute Respiratory Syndrome CoronavirusMicrobiology and Molecular Biology Reviews, 2005
- Development of antiviral therapy for severe acute respiratory syndromeAntiviral Research, 2005
- Virtual Screening of Novel Noncovalent Inhibitors for SARS-CoV 3C-like ProteinaseJournal of Chemical Information and Modeling, 2004
- Old drugs as lead compounds for a new disease? Binding analysis of SARS coronavirus main proteinase with HIV, psychotic and parasite drugsBioorganic & Medicinal Chemistry, 2004
- In Vitro Activity of Expanded-Spectrum Pyridazinyl Oxime Ethers Related to Pirodavir: Novel Capsid-Binding Inhibitors with Potent Antipicornavirus ActivityAntimicrobial Agents and Chemotherapy, 2004
- Coronavirus in severe acute respiratory syndrome (SARS)Trends in Molecular Medicine, 2003
- Koch's postulates fulfilled for SARS virusNature, 2003
- Potent inhibition of respiratory syncytial virus by polyoxometalates of several structural classesAntiviral Research, 1997